Iring Heisler

Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY‐876

Hölger Siebeneicher, Arwed Cleve, Hartmut Rehwinkel et al. · ChemMedChem · 2016 · 273 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Anetumab Ravtansine: A Novel Mesothelin-Targeting Antibody–Drug Conjugate Cures Tumors with Heterogeneous Target Expression Favored by Bystander Effect

Sven Golfier, Charlotte Kopitz, Antje Kahnert et al. · Molecular Cancer Therapeutics · 2014 · 253 citations

Medicine, Oncology, Pharmacology +17

<scp>BAY</scp> 87‐2243, a highly potent and selective inhibitor of hypoxia‐induced gene activation has antitumor activities by inhibition of mitochondrial complex I

Peter Ellinghaus, Iring Heisler, Kerstin Unterschemmann et al. · Cancer Medicine · 2013 · 226 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Mechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amides

Khyati Kapoor, Janet Finer-Moore, Bjørn Panyella Pedersen et al. · Proceedings of the National Academy of Sciences · 2016 · 215 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

A Colorimetric Assay for the Quantitation of Free Adenine Applied to Determine the Enzymatic Activity of Ribosome-Inactivating Proteins

Iring Heisler, Jutta Keller, R Tauber et al. · Analytical Biochemistry · 2002 · 103 citations

Life Sciences, Biochemistry, Molecular Biology +13